about
Analysis of primary visual cortex in dementia with Lewy bodies indicates GABAergic involvement associated with recurrent complex visual hallucinationsOlfaction and Aging: A Mini-ReviewNeurofibrillary tangle-predominant dementia: comparison with classical Alzheimer diseaseSpreading of amyloid, tau, and microvascular pathology in Alzheimer's disease: findings from neuropathological and neuroimaging studies.Amyloid PET and MRI in Alzheimer's disease and mild cognitive impairment.Concordance between epidermal growth factor receptor status in primary non-small-cell lung cancer and metastases: a post-mortem study.Reduction of RPT6/S8 (a Proteasome Component) and Proteasome Activity in the Cortex is Associated with Cognitive Impairment in Lewy Body DementiaQuantitative neuropathology: an update on automated methodologies and implications for large scale cohorts.Neurogenic abnormalities in Alzheimer's disease differ between stages of neurogenesis and are partly related to cholinergic pathologyFrontotemporal dementia and its subtypes: a genome-wide association study.Protease-resistant SOD1 aggregates in amyotrophic lateral sclerosis demonstrated by paraffin-embedded tissue (PET) blot.Vascular dementia: different forms of vessel disorders contribute to the development of dementia in the elderly brainA platelet protein biochip rapidly detects an Alzheimer's disease-specific phenotypeHypertension drives parenchymal β-amyloid accumulation in the brain parenchymaPrimary age-related tauopathy (PART): a common pathology associated with human agingPART, a distinct tauopathy, different from classical sporadic Alzheimer disease.The overlap between vascular disease and Alzheimer's disease--lessons from pathology.Quantitative neuropathological assessment to investigate cerebral multi-morbidity.Olfactory tau pathology in Alzheimer disease and mild cognitive impairment.The role of telomerase protein TERT in Alzheimer's disease and in tau-related pathology in vitro.Dynamin1 concentration in the prefrontal cortex is associated with cognitive impairment in Lewy body dementiaClinicians' ability to diagnose dementia with Lewy bodies is not affected by β-amyloid load.Cortical tau load is associated with white matter hyperintensitiesPost-mortem assessment in vascular dementia: advances and aspirations.Proteomic characterization of neuromelanin granules isolated from human substantia nigra by laser-microdissection.Sporadic cerebral amyloid angiopathy: pathology, clinical implications, and possible pathomechanisms.PTEN expression as a predictor for the response to trastuzumab-based therapy in Her-2 overexpressing metastatic breast cancer.The Microtubule-Associated Protein Tau and Its Relevance for Pancreatic Beta Cells.Neuropathological evaluation of mixed dementia.Deposition of amyloid β in the walls of human leptomeningeal arteries in relation to perivascular drainage pathways in cerebral amyloid angiopathy.Exome sequencing in dementia with Lewy bodiesAging-related tau astrogliopathy (ARTAG): harmonized evaluation strategy.Changes to the lateral geniculate nucleus in Alzheimer's disease but not dementia with Lewy bodies.Biomarkers for early diagnosis of Alzheimer disease: 'ALZheimer ASsociated gene'--a new blood biomarker?Genetic compendium of 1511 human brains available through the UK Medical Research Council Brain Banks Network Resource.Autopsy validation of 123I-FP-CIT dopaminergic neuroimaging for the diagnosis of DLB.Mitochondrial DNA point mutations and relative copy number in 1363 disease and control human brains.The relationship between subcortical tau pathology and Alzheimer's disease.Neuropathological correlates of cerebral multimorbidity.Olfactory bulb involvement in neurodegenerative diseases.
P50
Q27316760-C448FCBE-C5C7-499D-ACAB-E942C3EB2E2BQ28082742-9FBE0039-7EFE-4192-BB37-47F8DAB7DF23Q28272774-5E0FF816-F08C-461B-BC08-59EF9B7A1880Q30852116-014FB25D-C8ED-48E0-BEFD-17FF72074A84Q33466415-C6882D2D-6263-47EE-910E-F512EFFB14FCQ33547754-54883DFD-4191-4376-A078-DE00B5DC1594Q33708946-40B9A223-B9FE-4A04-93A0-46E9D5E79763Q33734079-798FA189-AFE6-4E3D-A3A9-FA5A6D2FCB37Q33822696-8B179B79-B263-490F-BD56-14800E03D986Q33955007-40F451B0-581C-4C06-8FA9-EAE499CBC7B0Q34143918-E5500A35-F392-417B-AB8E-909C2A6EC186Q34282041-C906C0D5-6948-487C-97EA-96DF0E20FED1Q34363475-56740DC5-F8E3-46A4-9197-6C19C79ADB8EQ34418827-ECA7F45D-1AE7-4A9D-9714-CA4DDC7FB921Q34445021-19EE2D55-F195-4F15-B8AF-6AF5CC180684Q34467464-CA1EF079-9C35-4ED1-8112-87CB6D2B4BCBQ34484708-7E101F96-B4B6-4744-818E-1AD48AC16707Q34584768-D8326990-9FEB-4A41-8289-ADF1A5AD346CQ34586398-72DFB6F1-034B-4BBC-BF59-26C9BAAE4E74Q35020283-E6AFF00E-D59C-496B-99C5-7F040E6BD105Q35022169-637CFA8A-0E8D-4E53-8574-C5EF7BAD3DD2Q35106476-9AE94DB2-201E-4656-A20B-950A97082807Q36108258-F4A2F715-AC8E-41B5-A118-17F460529469Q36124590-287A2CE1-DCC6-4F59-A85B-2D4BCAF25E93Q36191442-97A12A7D-4E78-495D-8FF4-9576C82B5337Q36260752-886299E2-646D-4E3A-977A-82CB1270DCF5Q36295269-AFC49397-0CA5-4653-8B51-F7130506E256Q36448430-ACEAA11E-6210-4B25-8CF0-583CE5E09442Q36745848-2325ADE5-6A54-4A9D-B813-584F5362F885Q36786388-1D5E1D24-BF45-42C0-BF96-B0AB18DA3B46Q36915437-106E5F67-0790-4CF2-BBB7-0312A9E74897Q36932383-518C821E-7770-4030-A0FB-FE5DB4217111Q37020745-C5F7B4EF-F090-4E24-AE01-E5A0538A1EF8Q37118083-1EDBFA7A-AE33-43B7-87E8-538C76CEC0A0Q37548493-AC193557-E1AB-4919-BE46-0BABA3B600A8Q37610726-E0185A48-A7B4-437B-952B-D18CD8A2F783Q37623036-F555F603-F437-4447-9602-CFC0A0035363Q38027942-43E81784-6F4B-45DA-820A-1B5E23F693F6Q38102759-383BDFC0-3C0F-4C5B-A418-59454235FA9AQ38189727-CB286124-B01A-44D9-A3BF-6CE1758E3E53
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0003-1636-1700
@en
name
Johannes Attems
@ast
Johannes Attems
@en
Johannes Attems
@es
Johannes Attems
@nl
type
label
Johannes Attems
@ast
Johannes Attems
@en
Johannes Attems
@es
Johannes Attems
@nl
altLabel
Johannes Attems
@en
prefLabel
Johannes Attems
@ast
Johannes Attems
@en
Johannes Attems
@es
Johannes Attems
@nl
P106
P21
P31
P4012
P496
0000-0003-1636-1700